T1	Measurement 20 41	Modified Hoehn & Yahr
T2	Value 42 49	stage 5
R1	Has_value Arg1:T1 Arg2:T2	
T3	Condition 117 139	wearing off phenomenon
A1	Optional T3
T4	Temporal 62 64;72 79	at on-time
T5	Temporal 62 64;83 91	at off-time
*	OR T4 T5
T6	Value 54 61	stage 5
R2	Has_value Arg1:T3 Arg2:T6	
T7	Scope 62 91	at eather on-time or off-time
R3	Has_scope Arg1:T6 Arg2:T7	
T8	Scope 54 139	stage 5 at eather on-time or off-time for the participant with wearing off phenomenon
*	OR T2 T8
T9	Condition 170 180	dyskinesia
T10	Qualifier 163 169	severe
R4	Has_qualifier Arg1:T9 Arg2:T10	
T11	Condition 212 228	systemic disease
T12	Undefined_semantics 212 228	systemic disease
T13	Qualifier 203 211	unstable
T14	Subjective_judgement 203 211	unstable
R5	Has_qualifier Arg1:T11 Arg2:T13	
T15	Measurement 253 290	Mini-Mental State Examinations (MMSE)
T16	Value 300 305	<= 24
R6	Has_value Arg1:T15 Arg2:T16	
T17	Condition 307 326	psychiatric disease
T18	Parsing_Error 231 327	The participant has a Mini-Mental State Examinations (MMSE) score of <= 24. psychiatric disease.
T19	Condition 385 397	hypertension
T20	Qualifier 362 384	clinically significant
T21	Subjective_judgement 362 384	clinically significant
R7	Has_qualifier Arg1:T19 Arg2:T20	
T22	Condition 407 464	reactions associated with ingestion of tyramine-rich food
T23	Undefined_semantics 407 464	reactions associated with ingestion of tyramine-rich food
*	OR T19 T22
T24	Procedure 496 522	neurosurgical intervention
T25	Condition 527 546	Parkinson's disease
R8	AND Arg1:T24 Arg2:T25	
T26	Condition 554 565	pallidotomy
T27	Condition 567 578	thalamotomy
T28	Condition 580 602	deep brain stimulation
*	OR T27 T28 T26
T29	Scope 554 602	pallidotomy, thalamotomy, deep brain stimulation
T30	Scope 496 546	neurosurgical intervention for Parkinson's disease
R9	Subsumes Arg1:T30 Arg2:T29	
T31	Procedure 635 668	transcranial magnetic stimulation
T32	Temporal 669 684	within 6 months
R10	Has_temporal Arg1:T31 Arg2:T32	
T33	Drug 714 724	selegiline
T34	Drug 726 735	pethidine
T35	Drug 737 745	tramadol
T36	Drug 747 756	reserpine
T37	Drug 760 770	methyldopa
T38	Temporal 771 785	within 90 days
*	OR T37 T36 T35 T34 T33
T39	Scope 714 770	selegiline, pethidine, tramadol, reserpine or methyldopa
R11	Has_temporal Arg1:T39 Arg2:T38	
T40	Parsing_Error 606 786	The participant has received transcranial magnetic stimulation within 6 months.The participant has received selegiline, pethidine, tramadol, reserpine or methyldopa within 90 days.
T41	Procedure 817 837	levodopa monotherapy
T42	Drug 817 825	levodopa
R12	AND Arg1:T41 Arg2:T42	
T43	Drug 843 863	psychoneurotic agent
T44	Drug 867 908	antiemetic medication of dopamine agonist
T45	Temporal 909 923	within 14 days
T46	Undefined_semantics 867 908	antiemetic medication of dopamine agonist
T47	Undefined_semantics 843 863	psychoneurotic agent
*	OR T44 T43 T42
T48	Scope 817 908	levodopa monotherapy, any psychoneurotic agent or antiemetic medication of dopamine agonist
R13	Has_temporal Arg1:T48 Arg2:T45	
T49	Drug 969 979	quetiapine
T50	Drug 983 994	domperidone
T51	Qualifier 1002 1013	stable dose
T52	Temporal 1026 1036	>= 14 days
R14	Has_temporal Arg1:T51 Arg2:T52	
*	OR T50 T49
T53	Scope 969 994	quetiapine or domperidone
R15	Has_qualifier Arg1:T53 Arg2:T51	
T54	Post-eligibility 1068 1150	The participant is required to take any of the excluded medications or treatments.
T55	Context_Error 1068 1150	The participant is required to take any of the excluded medications or treatments.
T56	Parsing_Error 1152 1218	The participant with laboratory data meeting any of the following:
T57	Measurement 1220 1230	Creatinine
T58	Value 1231 1265	>= 2 x upper limit of normal (ULN)
R16	Has_value Arg1:T57 Arg2:T58	
T59	Measurement 1267 1282	Total bilirubin
T60	Value 1283 1293	>= 2 x ULN
R17	Has_value Arg1:T59 Arg2:T60	
T61	Value 1306 1318	>= 1.5 x ULN
T62	Measurement 1302 1305	AST
T63	Measurement 1295 1298	ALT
*	OR T62 T63
T64	Scope 1295 1305	ALT or AST
R18	Has_value Arg1:T64 Arg2:T61	
T65	Measurement 1320 1323	ALP
T66	Value 1324 1334	>= 3 x ULN
R19	Has_value Arg1:T65 Arg2:T66	
T67	Post-eligibility 1336 1418	The participant has received any of the excluded medications or treatments during.
T68	Context_Error 1336 1418	The participant has received any of the excluded medications or treatments during.
